# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-10-080477
Filing Date
2010-04-09
Accepted
2010-04-09 15:53:54
Documents
10
Period of Report
2010-04-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d6k.htm | 6-K | 11798
2 | NOTICE OF ANNUAL AND SPECIAL MEETING | dex991.htm | EX-99.1 | 7335
3 | MANAGEMENT INFORMATION CIRCULAR DATED MARCH 26, 2010 | dex992.htm | EX-99.2 | 312797
4 | INSTRUMENT OF PROXY - ANNUAL & SPECIAL MEETING MAY 11, 2010 | dex993.htm | EX-99.3 | 762
5 | PROXY VOTING FORM | dex994.htm | EX-99.4 | 461
6 | GRAPHIC | g96466g32j34.jpg | GRAPHIC | 151619
7 | GRAPHIC | g96466g42i56.jpg | GRAPHIC | 164866
8 | GRAPHIC | g96466g73m27.jpg | GRAPHIC | 138825
9 | GRAPHIC | g96466logo-oncolytics.jpg | GRAPHIC | 10477
10 | GRAPHIC | g96466tx_pg06.jpg | GRAPHIC | 47050
| Complete submission text file | 0001193125-10-080477.txt |  | 1041912

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 10742610
SIC: 2834 Pharmaceutical Preparations